Pay in 4 interest-free payments of $7.09 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
When used concurrently with insulin or insulin secretagogues such as sulfonylureas or meglitinides, the risk of hypoglycemia may be increased, particularly during the initiation of therapy or following dose escalations
Its my pick during active training phases or when transitioning off a GLP-1 (or even used along side a GLP-1 to better preserve muscle)
Batch-level Certificate of Analysis information is available for every lot through Peptra Labs lab reports
Some common side effects may include: Irritation at the injection site Fatigue Nausea Storage Store at controlled room temperature
Chemical & Handling Information Type: Synthetic FOXO4-interacting peptide analog Peptide length: Short peptide (exact sequence per specification/lot) Appearance: White to off-white lyophilized powder Specifications Peptide: FOXO4-DRI Amount: 5 mg per vial Form: Lyophilized powder Purity: 99% (HPLC)
